| Accession Number | 0002114309-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 7, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Development | Ordinary Shares | โ | Jul 4, 2026 | Exercise/Conversion | 12,432 | โ | โ | 302,586 | Direct | โ | View Details | |
SVP, Clinical Development | Ordinary Shares | โ | Jul 6, 2026 | Sale | 4,485 | $0.89 | $3,991.65 | 298,101 | Direct | โ | View Details | |
SVP, Clinical Development | Restricted Share Units | Derivative | Jul 4, 2026 | Exercise/Conversion | 5,405 | $0.00 | $0.00 | 0 | Direct | โ | View Details |